Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hemangiosarcoma × TTI-621 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Mycosis Fungoides 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1 Dermatofibrosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1

Interventions

Doxorubicin 2 sintilimab 1 pazopanib 1 Trabectedin 1 TTI-621 1 Paclitaxel 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04996004 2024-12-11

TTI-621-03

Pfizer

Phase 2 Terminated

76 enrolled 53 charts

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡